Skip to main content
. 2016 Nov 3;7(49):80751–80764. doi: 10.18632/oncotarget.13037

Table 2. Clinicopathological characteristics of HCC patients according to NRAS and YWHAZ expression.

Characteristics NRAS mRNA expression (Mean ± SD) p value YWHAZ mRNA expression (Mean ± SD) p value NRAS protein expression (Mean ± SD) p value YWHAZ protein expression (Mean ± SD) p value
Age (years) 0.9688 0.0343* 0.0051* 0.7443
≥ 60 10.41 ± 0.5563 12.97 ± 0.8093 0.03212 ± 0.1406 0.01065 ± 0.3677
< 60 10.40 ± 0.6507 13.15 ± 0.7579 −0.03000 ± 0.1510 0.02714 ±0.2695
Gender 0.6340 0.6491 0.2213 0.0683
Female 10.38 ± 0.5816 13.03 ± 0.8047 −0.02415 ± 0.1698 0.07746 ± 0.3911
Male 10.42 ± 0.6102 13.07 ± 0.7845 0.009835 ± 0.1460 −0.01600 ± 0.2923
Edmondson–Steiner grade 0.0130* < 0.0001* 0.0002* 0.0111*
G1-2 10.34 ± 0.5769 12.91 ± 0.7726 0.03662 ± 0.1268 −0.02295 ± 0.3068
G3-4 10.51 ± 0.6300 13.32 ± 0.7524 −0.04835 ± 0.1692 0.1079 ± 0.3628
TNM stage 0.1187 0.4169 0.0702 0.2091
I–II 10.36 ± 0.5898 13.04 ± 0.7955 0.02140 ± 0.1468 −0.0005718 ± 0.3043
III–IV 10.47 ± 0.6057 13.12 ± 0.8017 -0.02070 ± 0.1446 0.06635 ± 0.3835
AFP level (ng/ml) 0.6538 0.0011* < 0.0001* 0.0095*
≥ 400 10.40 ± 0.6461 13.29 ± 0.7759 −0.07200 ± 0.1501 0.1445 ± 0.4223
< 400 10.36 ± 0.5695 12.93 ± 0.7823 0.04388 ± 0.1234 -0.02912 ± 0.2743
Alcohol consumption 0.1878 0.6499 0.4258 0.9629
Yes 10.35 ± 0.5687 13.00 ± 0.8031 0.02566 ± 0.1423 0.01069 ± 0.3494
No 10.43 ± 0.5989 13.04 ± 0.7736 0.007446 ± 0.1476 0.008242 ± 0.3277
HBV/HCV infection 0.9849 0.5097 0.2440 0.4237
Yes 10.40 ± 0.5671 13.07 ± 0.7635 0.03754 ± 0.1193 −0.02553 ± 0.2648
No 10.40 ± 0.6132 13.01 ± 0.8081 0.006684 ± 0.1537 0.02321 ± 0.3561
Vascular invasion 0.6740 0.1856 0.0597 0.0151*
None 10.36 ± 0.6012 12.98 ± 0.7891 0.02779 ± 0.1344 −0.04272 ± 0.2652
Micro/macro 10.39 ± 0.5886 13.11 ± 0.7999 −0.01938 ± 0.1587 0.09696 ± 0.4233